A comprehensive intervention for cardiovascular disease prevention in selected primary health care facilities in Capricorn District, South Africa: An effectiveness-implementation study - Trial PACTR201906616852062
Access comprehensive clinical trial information for PACTR201906616852062 through Pure Global AI's free database. This Not Applicable trial is sponsored by University of Limpopo and is currently Recruiting. The study focuses on Cardiology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Limpopo
European Commission Horizon 2020
Timeline & Enrollment
Not Applicable
May 01, 2019
Dec 31, 2021
Summary
South Africa, just like other developing countries, is undergoing a process of epidemiological transition from infectious to non-communicable diseases (NCDs). While the burden of infectious disease such as HIV/AIDS and TB epidemic still predominate in terms of both morbidity and mortality, there are now other emerging NCD epidemics. NCDs, mainly cardiovascular diseases (CVDs), cancers, chronic respiratory diseases and diabetes represent a leading threat to human health and development. The prevalence of these epidemics coincide with the rise in urbanization, industrialization, economic transition and health services that are not always adequately equipped to deal with the issues, more people are becoming ill and dying from the diseases. The broad aim of the project is to implement and evaluate a comprehensive CVD prevention programme in selected rural and semi-urban primary health care facilities in Capricorn District, South Africa. The study also aims to identify and document the barriers and facilitators associated with the implementation of the project.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201906616852062
Non-Device Trial

